Inspire Medical Systems, Inc.
General ticker "INSP" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $3.0B (TTM average)
Inspire Medical Systems, Inc. does not follow the US Stock Market performance with the rate: -25.8%.
Estimated limits based on current volatility of 2.1%: low 39.60$, high 41.64$
Factors to consider:
- Total employees count: 1246 (+23.2%) as of 2024
- US accounted for 96.0% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Cybersecurity threats, Product liability, Third-party risks, Regulatory and compliance, Demand forecasting
- Current price 39.5% below estimated low
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [66.82$, 126.20$]
- 2026-12-31 to 2027-12-31 estimated range: [68.74$, 127.19$]
Financial Metrics affecting the INSP estimates:
- Negative: with PPE of 37.7 at the end of fiscal year the price was high
- Positive: -5.39 < Operating profit margin, % of 5.59
- Positive: Investing cash flow per share per price, % of 0.75 > -0.60
- Positive: Return on assets ratio (scaled to [-100,100]) of 13.81 > 6.06
- Negative: negative Industry operating income (median)
- Negative: negative Industry operating cash flow (median)
- Positive: Shareholder equity ratio, % of 86.10 > 64.29
- Positive: Industry inventory ratio change (median), % of -0.30 <= -0.16
Short-term INSP quotes
Long-term INSP plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $624.80MM | $802.80MM | $911.98MM |
| Operating Expenses | $665.07MM | $766.72MM | $861.03MM |
| Operating Income | $-40.27MM | $36.08MM | $50.95MM |
| Non-Operating Income | $20.36MM | $22.37MM | $14.74MM |
| Interest Expense | $0.00MM | $0.02MM | $0.14MM |
| R&D Expense | $116.54MM | $114.13MM | $103.17MM |
| Income(Loss) | $-19.91MM | $58.45MM | $65.70MM |
| Taxes | $1.25MM | $4.94MM | $-79.72MM |
| Net Income(Loss)* | $-21.15MM | $53.51MM | $145.42MM |
| Stockholders Equity | $572.51MM | $689.70MM | $781.16MM |
| Inventory | $33.88MM | $80.12MM | $145.29MM |
| Assets | $676.81MM | $808.38MM | $907.32MM |
| Operating Cash Flow | $24.65MM | $130.25MM | $116.98MM |
| Capital expenditure | $23.63MM | $39.12MM | $38.50MM |
| Investing Cash Flow | $-294.82MM | $-113.12MM | $21.45MM |
| Financing Cash Flow | $13.95MM | $-52.39MM | $-183.45MM |
| Earnings Per Share** | $-0.72 | $1.80 | $4.95 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.